Gelion PLC Total Voting Rights (9437C)

TIDMGELN

RNS Number : 9437C

Gelion PLC

28 February 2022

Gelion plc

("Gelion" or the "Company")

Total Voting Rights

In compliance with the FCA's Disclosure Guidance and Transparency Rules (the "Rules"), the Company announces that, as at the date of this announcement, it has 107,134,839 ordinary shares of 0.1 pence each in issue. The Company does not hold any shares in treasury and all of the ordinary shares have equal voting rights.

The figure of 107,134,839 ordinary shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.

CONTACTS

 
 Gelion plc                                             via Tavistock 
  Andrew Grimes, Chief Executive Officer 
  Thomas Maschmeyer, Founder and Principal 
  Technology Advisor 
  Marcus Strom, Corporate Communications 
 finnCap Ltd (Nominated Adviser and Sole 
  Broker)                                            [phone] 
 Corporate Finance 
  Christopher Raggett 
  Seamus Fricker 
  Fergus Sullivan 
  ECM 
  Barney Hayward 
 Tavistock (Financial PR Adviser)                    [phone] 
  Simon Hudson                                 [e-mail] 
  Nick Elwes 
  Rebecca Hislaire 
 
 

Notes to editors

Gelion (AIM: GELN) is a publicly listed company on the London Stock Exchange AIM market. It was founded as a spin-out from the University of Sydney in 2015 by Professor Thomas Maschmeyer, one of the world's leading chemists who was awarded the Australian Prime Minister's Prize for Innovation 2020.

Gelion is a global renewable-energy storage innovator. By designing leading-edge battery technology for stationary and mobile energy, the Company supports the transition to a sustainable economy while delivering value for customers and investors.

-- The Gelion Endure battery uses low-cost, abundant raw materials and is based on a chemistry that is highly resistant to fire.

-- The batteries are scalable, using lead-acid battery manufacturing technology, and the Company expects to develop megawatt-hour capacity for large-scale infrastructure, including for solar and wind farms.

-- With applications in agriculture, mining, water management and irrigation the battery is highly adaptable for off-grid use.

In addition to investing in the growth of its zinc-bromide technology, the Company will use funding to develop its mobile energy division to enhance existing lithium-ion and lithium-sulfur battery technologies used in electric vehicles and the emerging market in electric aviation.

For the mobile market, Gelion's technology pipeline includes:

-- Highly tuneable, low-cost silicon nanoparticle additives for next-generation advanced lithium-ion batteries, which are safer and have higher energy density.

-- A low-cost additive, which increases the lifetime of lithium-sulfur batteries by more than four times, delivering up to three times higher energy by weight than conventional lithium-ion batteries.

Using additive technology developed by its R&D team, which cooperates closely with scientists at the School of Chemistry and the University of Sydney Nano Institute, Gelion will develop and license additives for advanced lithium-silicon and lithium-sulfur technologies for ultra-high-density batteries to extend the cycle-life and safety of mobile energy storage.

Gelion also recently announced a partnership with Battery Energy Power Solutions in Sydney to manufacture and distribute its zinc-bromide batteries for the Australian market.

Gelion qualified for the LSE Green Economy Mark which recognises London-listed companies and funds that derive more than 50% of their revenues from products and services that are contributing the environmental objectives such as climate change mitigation and adaptation, waste and pollution reduction, and the circular economy.

To find out more, please visit: www.gelion.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVREAEAXAALAEAA

(END) Dow Jones Newswires

February 28, 2022 02:00 ET (07:00 GMT)